Ivanova O A, Tsyrlina E V, Moiseenko V M, Semiglazov V F
Vopr Onkol. 1986;32(6):71-6.
Estrogen receptor (ER) levels were measured in 280 breast cancer patients (mean age 54.5 years). Progesterone receptor (PR) levels were assayed in 101 of them. 61.4% of cases were at stages I and IIa. No significant difference in 2-year survival was established between ER-negative and ER-positive patients (96.7 and 96.0%, respectively). Two-year survival rate and recurrence--free survival for PR-positive cases were significantly higher than those for PR-negative ones (p greater than 0.05).
对280例乳腺癌患者（平均年龄54.5岁）进行了雌激素受体（ER）水平检测。其中101例患者进行了孕激素受体（PR）水平检测。61.4%的病例处于I期和IIa期。ER阴性和ER阳性患者之间的2年生存率无显著差异（分别为96.7%和96.0%）。PR阳性病例的2年生存率和无复发生存率显著高于PR阴性病例（p>0.05）。
